Clinical Trial Update: Study of Salirasib to Treat Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

The document reports the completion of a Phase 2 clinical trial evaluating salirasib for non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Salirasib (salirasib)

Snippet

Sponsor: Concordia Pharmaceuticals, Inc | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 2 | Status: COMPLETED